Comerica, Inc (CMA) concluded trading on Wednesday at a closing price of $66.63, with 4.77 million shares of worth about $317.53 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 0.38% during that period and on July 23, 2025 the price saw a gain of about 2.07%. Currently the company’s common shares owned by public are about 131.41M shares, out of which, 130.24M shares are available for trading.
Stock saw a price change of 8.98% in past 5 days and over the past one month there was a price change of 16.16%. Year-to-date (YTD), CMA shares are showing a performance of 32.15% which increased to 7.73% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $48.12 but also hit the highest price of $73.45 during that period. The average intraday trading volume for Comerica, Inc shares is 1.62 million. The stock is currently trading 6.74% above its 20-day simple moving average (SMA20), while that difference is up 12.21% for SMA50 and it goes to 8.47% higher than SMA200.
Comerica, Inc (NYSE: CMA) currently have 131.41M outstanding shares and institutions hold larger chunk of about 85.78% of that.
The stock has a current market capitalization of $8.76B and its 3Y-monthly beta is at 0.96. PE ratio of stock for trailing 12 months is 12.80, while it has posted earnings per share of $5.20 in the same period. Its PEG reads 1.94 while making debt-to-equity ratio of 1.27. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CMA, volatility over the week remained 3.53% while standing at 2.49% over the month.
Stock’s fiscal year EPS is expected to rise by 4.64% while it is estimated to increase by 7.47% in next year. EPS is likely to grow at an annualized rate of 6.61% for next 5-years, compared to annual growth of -8.69% made by the stock over the past 5-years.
Coverage by Jefferies stated Comerica, Inc (CMA) stock as an Underperform in their note to investors on May 21, 2025, suggesting a price target of $47 for the stock. On April 22, 2025, JP Morgan Downgrade their recommendations, while on April 22, 2025, Evercore ISI Downgrade their ratings for the stock with a price target of $50. Stock get a Neutral rating from UBS on April 10, 2025.
